FDA Inspection 841121 — Lilly Del Caribe, Inc

Lilly Del Caribe, Inc — FEI 2619243

The FDA completed an inspection of Lilly Del Caribe, Inc on Jul 22, 2013 in Carolina, PR. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 22, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Carolina, PR (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
1774921 CFR 212.30(a)Prevention of contamination
202821 CFR 211.192Extent of discrepancy, failure investigations
890721 CFR 314.81(b)(1)(ii)Contamination, chemical or physical change, deterioration

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.